Anti‐PD‐L1 treatment alone did not significantly increase the infiltration of CD8‐positive T‐lymphocytes into CT‐26 tumours, nor did it further enhance the increase observed in response to ADC‐159 (Figure 7C). This evidence concerns the gene CD8A and neoplasm.